A study set out to assess the impact of dupliumab on daily life functionality in patients with atopic dermatitis using a pooled analysis of the SOLO trials.
Read more at the Journal of the American Academy of Dermatology.
Does dupilumab reduce absenteeism in patients with moderate-to-severe atopic dermatitis?
